ASTRAZENECA PLC (AZN)
Clinical trial NCT03682068 updates: 1. completion date: 2026-04-29 → 2027-06-01 2. primary completion date: 2026-04-29 → 2026-06-01 3. enrollment: not set → 1246 participants
Clinical trial NCT03682068 updates: 1. completion date: 2026-04-29 → 2027-06-01 2. primary completion date: 2026-04-29 → 2026-06-01 3. enrollment: not set → 1246 participants
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical